Please Wait.....
Report
Europe Non-Invasive Prenatal Testing (NIPT) Market By Product (Consumables, Instruments), By Test Type (Materni 21, Harmony, Panaroma, Verifi, NIFTY, Others), By Application (Trisomy, Microdeletion Syndrome, Others), By End User (Diagnostic Laboratories, Hospitals, Others), By Country, Competition, Forecast and Opportunities, 2020-2030F
Market Report I 2025-04-25 I 133 Pages I TechSci Research
Market Overview
The Europe Non-Invasive Prenatal Testing (NIPT) Market was valued at USD 868.11 Million in 2024 and is projected to reach USD 1914.06 Million by 2030, growing at a CAGR of 14.06% during the forecast period. The market is witnessing strong growth driven by heightened awareness of genetic disorders and the rising demand for safer prenatal screening options. With maternal age steadily increasing across Europe, the risk of chromosomal abnormalities is also rising, prompting more expectant mothers to choose non-invasive alternatives to traditional procedures like amniocentesis. NIPT offers accurate results through a simple blood test, eliminating the risk of miscarriage and improving patient compliance. Supportive government policies, expanded private healthcare access, and advancements in genomic technologies are facilitating market expansion. The use of AI for test interpretation and the trend toward personalized medicine are broadening the scope of NIPT, while multiplex assay development and partnerships between diagnostics companies and healthcare providers are streamlining service delivery and improving accessibility.
Key Market Drivers
Rising Maternal Age and Associated Risk of Chromosomal Abnormalities
The growing maternal age across Europe significantly drives demand in the Non-Invasive Prenatal Testing (NIPT) market. As more women delay childbirth due to career, financial, and lifestyle choices, the likelihood of chromosomal disorders like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13) increases. According to the Office for National Statistics (ONS), the average age of mothers in England and Wales rose to 30.9 years in 2023. This demographic trend directly correlates with greater use of NIPT, which is non-invasive, highly accurate, and free of the miscarriage risks posed by conventional methods such as amniocentesis or chorionic villus sampling (CVS). NIPT uses maternal blood samples to analyze cell-free fetal DNA, providing a safe and reliable alternative for prenatal screening. In the UK, the National Health Service (NHS) has integrated NIPT into standard prenatal care, improving accessibility. As the average maternal age continues to rise across Europe, demand for accurate, non-invasive screening methods like NIPT is expected to grow substantially, reinforcing its role in modern prenatal care.
Key Market Challenges
High Cost of NIPT
The elevated cost of non-invasive prenatal testing (NIPT) remains a key barrier to widespread adoption across Europe. Advanced technologies such as next-generation sequencing and the need for specialized lab infrastructure contribute to the high per-test expense. In many countries, public healthcare systems do not fully reimburse NIPT, placing the financial burden on patients. This results in limited access for individuals from lower and middle-income groups, restricting overall market penetration. Additionally, pricing inconsistencies and variable insurance coverage create further challenges for both patients and providers. The cost factor also affects healthcare professionals' willingness to recommend NIPT and poses budget constraints for broader inclusion in public prenatal screening programs. For diagnostic firms, high operational and production expenses constrain market entry and expansion opportunities. Addressing these financial challenges will require expanded insurance support, government funding, and cost-efficient technological advancements to ensure equitable access to NIPT across the region.
Key Market Trends
Integration of NIPT into Routine Prenatal Care
One of the most significant trends in the European NIPT market is its growing incorporation into routine prenatal care. Advancements in genomics and the shift toward personalized medicine are making NIPT a standard first-line screening method. The test's accuracy in identifying common chromosomal abnormalities-along with its safety and non-invasive nature-has led healthcare providers to recommend it earlier in pregnancy. National healthcare programs in countries like Belgium and the Netherlands now offer government-funded NIPT to all pregnant women, resulting in high adoption rates. For instance, second-line NIPT uptake in regions like Andalucia, Spain has reached over 93% for eligible cases. Integration into care protocols enhances patient awareness and enables informed decision-making during early antenatal visits. Additionally, user-friendly platforms and automated analysis tools are improving operational efficiency for clinicians. This mainstreaming of NIPT is paving the way for broader utilization and supporting the transition to comprehensive, individualized prenatal care across Europe.
Key Market Players
- F. Hoffmann-La Roche Ltd.
- Eurofins LifeCodexx GmbH
- Yourgene Health plc
- Centogene N.V.
- QIAGEN N.V.
- Eluthia GmbH
- Life Genomics AB
- TATAA Biocenter AB
- Genoma SA
- Synlab International GmbH
Report Scope:
In this report, the Europe Non-Invasive Prenatal Testing (NIPT) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Europe Non-Invasive Prenatal Testing (NIPT) Market, By Product:
o Consumables
o Instruments
- Europe Non-Invasive Prenatal Testing (NIPT) Market, By Test Type:
o Materni 21
o Harmony
o Panaroma
o Verifi
o NIFTY
o Others
- Europe Non-Invasive Prenatal Testing (NIPT) Market, By Application:
o Trisomy
o Microdeletion Syndrome
o Others
- Europe Non-Invasive Prenatal Testing (NIPT) Market, By End User:
o Diagnostic Laboratories
o Hospitals
o Others
- Europe Non-Invasive Prenatal Testing (NIPT) Market, By Country:
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Poland
o Bulgaria
o Finland
o Portugal
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Europe Non-Invasive Prenatal Testing (NIPT) Market.
Available Customizations:
Europe Non-Invasive Prenatal Testing (NIPT) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Instruments)
5.2.2. By Test Type (Materni 21, Harmony, Panaroma, Verifi, NIFTY, Others)
5.2.3. By Application (Trisomy, Microdeletion Syndrome, Others)
5.2.4. By End User (Diagnostic Laboratories, Hospitals, Others)
5.2.5. By Country
5.2.6. By Company (2024)
5.3. Market Map
6. Germany Non-Invasive Prenatal Testing (NIPT) Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Test Type
6.2.3. By Application
6.2.4. By End User
7. France Non-Invasive Prenatal Testing (NIPT) Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Test Type
7.2.3. By Application
7.2.4. By End User
8. United Kingdom Non-Invasive Prenatal Testing (NIPT) Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Test Type
8.2.3. By Application
8.2.4. By End User
9. Italy Non-Invasive Prenatal Testing (NIPT) Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Test Type
9.2.3. By Application
9.2.4. By End User
10. Spain Non-Invasive Prenatal Testing (NIPT) Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Test Type
10.2.3. By Application
10.2.4. By End User
11. Russia Non-Invasive Prenatal Testing (NIPT) Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Test Type
11.2.3. By Application
11.2.4. By End User
12. Poland Non-Invasive Prenatal Testing (NIPT) Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Product
12.2.2. By Test Type
12.2.3. By Application
12.2.4. By End User
13. Bulgaria Non-Invasive Prenatal Testing (NIPT) Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Product
13.2.2. By Test Type
13.2.3. By Application
13.2.4. By End User
14. Finland Non-Invasive Prenatal Testing (NIPT) Market Outlook
14.1. Market Size & Forecast
14.1.1. By Value
14.2. Market Share & Forecast
14.2.1. By Product
14.2.2. By Test Type
14.2.3. By Application
14.2.4. By End User
15. Portugal Non-Invasive Prenatal Testing (NIPT) Market Outlook
15.1. Market Size & Forecast
15.1.1. By Value
15.2. Market Share & Forecast
15.2.1. By Product
15.2.2. By Test Type
15.2.3. By Application
15.2.4. By End User
16. Market Dynamics
16.1. Drivers
16.2. Challenges
17. Market Trends & Developments
17.1. Merger & Acquisition (If Any)
17.2. Product Launches (If Any)
17.3. Recent Developments
18. Europe Non-Invasive Prenatal Testing (NIPT) Market: SWOT Analysis
19. Porters Five Forces Analysis
19.1. Competition in the Industry
19.2. Potential of New Entrants
19.3. Power of Suppliers
19.4. Power of Customers
19.5. Threat of Substitute Products
20. Competitive Landscape
20.1. F. Hoffmann-La Roche Ltd.
20.1.1. Business Overview
20.1.2. Company Snapshot
20.1.3. Products & Services
20.1.4. Financials (As Reported)
20.1.5. Recent Developments
20.1.6. Key Personnel Details
20.1.7. SWOT Analysis
20.2. Eurofins LifeCodexx GmbH
20.3. Yourgene Health plc
20.4. Centogene N.V.
20.5. QIAGEN N.V.
20.6. Eluthia GmbH
20.7. Life Genomics AB
20.8. TATAA Biocenter AB
20.9. Genoma SA
20.10. Synlab International GmbH
21. Strategic Recommendations
22. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security